Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 29 studies | 37% ± 17% | |
classical monocyte | 24 studies | 44% ± 21% | |
monocyte | 20 studies | 46% ± 23% | |
conventional dendritic cell | 20 studies | 36% ± 10% | |
non-classical monocyte | 17 studies | 41% ± 21% | |
dendritic cell | 13 studies | 32% ± 17% | |
myeloid cell | 9 studies | 39% ± 20% | |
neutrophil | 6 studies | 61% ± 24% | |
mononuclear phagocyte | 6 studies | 45% ± 15% | |
alveolar macrophage | 5 studies | 24% ± 9% | |
leukocyte | 5 studies | 30% ± 6% | |
intermediate monocyte | 4 studies | 48% ± 20% | |
hematopoietic stem cell | 4 studies | 30% ± 6% | |
hematopoietic precursor cell | 3 studies | 32% ± 15% | |
monocyte-derived dendritic cell | 3 studies | 60% ± 32% | |
microglial cell | 3 studies | 39% ± 22% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 62% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 4 studies | 26% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 96% | 1282.92 | 554 / 578 | 83% | 16.25 | 954 / 1155 |
stomach | 75% | 1346.01 | 269 / 359 | 87% | 34.61 | 250 / 286 |
intestine | 47% | 187.13 | 455 / 966 | 87% | 30.45 | 461 / 527 |
bladder | 52% | 86.81 | 11 / 21 | 77% | 30.52 | 389 / 504 |
esophagus | 31% | 94.28 | 451 / 1445 | 86% | 30.27 | 157 / 183 |
kidney | 52% | 91.74 | 46 / 89 | 58% | 5.17 | 519 / 901 |
brain | 41% | 160.66 | 1085 / 2642 | 67% | 14.69 | 470 / 705 |
spleen | 100% | 1172.62 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 2063.54 | 887 / 929 | 0% | 0 | 0 / 0 |
ovary | 21% | 53.33 | 37 / 180 | 73% | 7.92 | 314 / 430 |
tonsil | 0% | 0 | 0 / 0 | 93% | 24.95 | 42 / 45 |
uterus | 17% | 30.51 | 29 / 170 | 66% | 16.59 | 304 / 459 |
pancreas | 23% | 36.15 | 77 / 328 | 56% | 7.26 | 99 / 178 |
breast | 16% | 25.88 | 72 / 459 | 59% | 5.28 | 664 / 1118 |
adrenal gland | 41% | 139.60 | 107 / 258 | 28% | 5.16 | 64 / 230 |
prostate | 43% | 111.04 | 105 / 245 | 24% | 2.05 | 122 / 502 |
thymus | 21% | 35.58 | 138 / 653 | 41% | 2.78 | 248 / 605 |
lymph node | 0% | 0 | 0 / 0 | 62% | 11.09 | 18 / 29 |
skin | 21% | 38.42 | 376 / 1809 | 40% | 9.45 | 190 / 472 |
liver | 35% | 67.81 | 78 / 226 | 13% | 0.93 | 51 / 406 |
adipose | 35% | 536.42 | 423 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 30% | 99.92 | 402 / 1335 | 0% | 0 | 0 / 0 |
heart | 23% | 114.28 | 200 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.66 | 5 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007254 | Biological process | JNK cascade |
GO_0050796 | Biological process | regulation of insulin secretion |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_0006954 | Biological process | inflammatory response |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0070372 | Biological process | regulation of ERK1 and ERK2 cascade |
GO_0050999 | Biological process | regulation of nitric-oxide synthase activity |
GO_0035505 | Biological process | positive regulation of myosin light chain kinase activity |
GO_0046827 | Biological process | positive regulation of protein export from nucleus |
GO_0007267 | Biological process | cell-cell signaling |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0006955 | Biological process | immune response |
GO_0033092 | Biological process | positive regulation of immature T cell proliferation in thymus |
GO_0032725 | Biological process | positive regulation of granulocyte macrophage colony-stimulating factor production |
GO_0097192 | Biological process | extrinsic apoptotic signaling pathway in absence of ligand |
GO_0043407 | Biological process | negative regulation of MAP kinase activity |
GO_0050767 | Biological process | regulation of neurogenesis |
GO_0030213 | Biological process | hyaluronan biosynthetic process |
GO_0035234 | Biological process | ectopic germ cell programmed cell death |
GO_0010573 | Biological process | vascular endothelial growth factor production |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_0051781 | Biological process | positive regulation of cell division |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
GO_0031622 | Biological process | positive regulation of fever generation |
GO_0051044 | Biological process | positive regulation of membrane protein ectodomain proteolysis |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0060252 | Biological process | positive regulation of glial cell proliferation |
GO_0048143 | Biological process | astrocyte activation |
GO_0007165 | Biological process | signal transduction |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0030593 | Biological process | neutrophil chemotaxis |
GO_0031394 | Biological process | positive regulation of prostaglandin biosynthetic process |
GO_1900745 | Biological process | positive regulation of p38MAPK cascade |
GO_0050996 | Biological process | positive regulation of lipid catabolic process |
GO_0060559 | Biological process | positive regulation of calcidiol 1-monooxygenase activity |
GO_0030730 | Biological process | sequestering of triglyceride |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0009743 | Biological process | response to carbohydrate |
GO_0045429 | Biological process | positive regulation of nitric oxide biosynthetic process |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0010829 | Biological process | negative regulation of glucose transmembrane transport |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0032308 | Biological process | positive regulation of prostaglandin secretion |
GO_1903597 | Biological process | negative regulation of gap junction assembly |
GO_0070487 | Biological process | monocyte aggregation |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0030949 | Biological process | positive regulation of vascular endothelial growth factor receptor signaling pathway |
GO_0043122 | Biological process | regulation of canonical NF-kappaB signal transduction |
GO_0001660 | Biological process | fever generation |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0007566 | Biological process | embryo implantation |
GO_0045833 | Biological process | negative regulation of lipid metabolic process |
GO_0060355 | Biological process | positive regulation of cell adhesion molecule production |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0097398 | Biological process | cellular response to interleukin-17 |
GO_0046627 | Biological process | negative regulation of insulin receptor signaling pathway |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0032743 | Biological process | positive regulation of interleukin-2 production |
GO_0043406 | Biological process | positive regulation of MAP kinase activity |
GO_0014805 | Biological process | smooth muscle adaptation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0010575 | Biological process | positive regulation of vascular endothelial growth factor production |
GO_0071639 | Biological process | positive regulation of monocyte chemotactic protein-1 production |
GO_0034116 | Biological process | positive regulation of heterotypic cell-cell adhesion |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0150078 | Biological process | positive regulation of neuroinflammatory response |
GO_0050691 | Biological process | regulation of defense response to virus by host |
GO_1903140 | Biological process | regulation of establishment of endothelial barrier |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_2000556 | Biological process | positive regulation of T-helper 1 cell cytokine production |
GO_0045917 | Biological process | positive regulation of complement activation |
GO_0033198 | Biological process | response to ATP |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0002711 | Biological process | positive regulation of T cell mediated immunity |
GO_0070498 | Biological process | interleukin-1-mediated signaling pathway |
GO_0050805 | Biological process | negative regulation of synaptic transmission |
GO_0070555 | Biological process | response to interleukin-1 |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_1902680 | Biological process | positive regulation of RNA biosynthetic process |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0050995 | Biological process | negative regulation of lipid catabolic process |
GO_0010718 | Biological process | positive regulation of epithelial to mesenchymal transition |
GO_0006915 | Biological process | apoptotic process |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_2001240 | Biological process | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO_0045840 | Biological process | positive regulation of mitotic nuclear division |
GO_0050768 | Biological process | negative regulation of neurogenesis |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0070164 | Biological process | negative regulation of adiponectin secretion |
GO_0005576 | Cellular component | extracellular region |
GO_0005615 | Cellular component | extracellular space |
GO_0005764 | Cellular component | lysosome |
GO_0030141 | Cellular component | secretory granule |
GO_0005829 | Cellular component | cytosol |
GO_0005149 | Molecular function | interleukin-1 receptor binding |
GO_0005125 | Molecular function | cytokine activity |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0005515 | Molecular function | protein binding |
GO_0005178 | Molecular function | integrin binding |
Gene name | IL1B |
Protein name | Interleukin-1 beta (IL-1 beta) (Catabolin) Multifunctional fusion protein [Includes: Interleukin-1; Interleukin-1 beta] Interleukin 1 beta Interleukin-1 beta |
Synonyms | IL1F2 IL1b |
Description | FUNCTION: Potent pro-inflammatory cytokine . Initially discovered as the major endogenous pyrogen, induces prostaglandin synthesis, neutrophil influx and activation, T-cell activation and cytokine production, B-cell activation and antibody production, and fibroblast proliferation and collagen production . Promotes Th17 differentiation of T-cells. Synergizes with IL12/interleukin-12 to induce IFNG synthesis from T-helper 1 (Th1) cells . Plays a role in angiogenesis by inducing VEGF production synergistically with TNF and IL6 . Involved in transduction of inflammation downstream of pyroptosis: its mature form is specifically released in the extracellular milieu by passing through the gasdermin-D (GSDMD) pore . Acts as a sensor of S.pyogenes infection in skin: cleaved and activated by pyogenes SpeB protease, leading to an inflammatory response that prevents bacterial growth during invasive skin infection . . FUNCTION: Potent pro-inflammatory cytokine. Initially discovered as the major endogenous pyrogen, induces prostaglandin synthesis, neutrophil influx and activation, T-cell activation and cytokine production, B-cell activation and antibody production, and fibroblast proliferation and collagen production. Promotes Th17 differentiation of T-cells. Synergizes with IL12/interleukin-12 to induce IFNG synthesis from T-helper 1 (Th1) cells. Plays a role in angiogenesis by inducing VEGF production synergistically with TNF and IL6. Involved in transduction of inflammation downstream of pyroptosis: its mature form is specifically released in the extracellular milieu by passing through the gasdermin-D (GSDMD) pore. . FUNCTION: Potent pro-inflammatory cytokine. Initially discovered as the major endogenous pyrogen, induces prostaglandin synthesis, neutrophil influx and activation, T-cell activation and cytokine production, B-cell activation and antibody production, and fibroblast proliferation and collagen production. Promotes Th17 differentiation of T-cells. Synergizes with IL12/interleukin-12 to induce IFNG synthesis from T-helper 1 (Th1) cells. Plays a role in angiogenesis by inducing VEGF production synergistically with TNF and IL6. Involved in transduction of inflammation downstream of pyroptosis: its mature form is specifically released in the extracellular milieu by passing through the gasdermin-D (GSDMD) pore. . |
Accessions | B5BUQ8 P01584 ENST00000263341.7 A0AA51YZX7 O43645 ENST00000416750.1 C9JSC2 C9JVK0 ENST00000432018.5 ENST00000418817.5 C9JWV2 |